FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051578523> ?p ?o ?g. }

• W2051578523 endingPage "A75" @default.
• W2051578523 startingPage "A74" @default.
• W2051578523 abstract "<h3>Introduction</h3> Successful treatment of STEMI requires early diagnosis and urgent passivation of the culprit lesion by antithrombotic therapy and mechanical revascularisation. A delicate balance exists between the risk of thrombosis and bleeding, consequently the choice of antithrombotic therapy is critical. Bivalirudin, a direct thrombin inhibitor, has been shown to offer a superior safety profile over heparin and GP2b3a inhibition in STEMI (Horizons-AMI). Similarly, the novel P2Y12-receptor inhibitor, Prasugrel, achieves faster and more consistent platelet inhibition than clopidogrel with improved clinical outcomes in STEMI (TRITON-TIMI 38). Although untested in a randomised clinical trial, the combination of bivalirudin and prasugrel for the treatment of STEMI appears to offer fast and effective inhibition of thrombosis with an acceptable bleeding profile. A randomised trial is in progress (BRAVE 4) but data will not be available until 2013. <h3>Methods</h3> Since June 2010 our preferred treatment strategy for patients presenting with STEMI has been pre-loading with prasugrel 60 mg and peri-procedural bivalirudin (0.75 mg/kg bolus followed by an infusion of 1.75 mg/kg/h). Patients >75 yrs, <65 kg, with a history of cerebrovascular accident, pre-treated with clopidogrel or intubated without NG tube access were excluded and received treatment according to operator preference. The preferred access site was the radial artery and all operators were experienced in performing percutaneous coronary intervention from this route. Patients were discharged on lifelong aspirin and prasugrel 10 mg for 12 months. Additionally, patients routinely received statin, ACE inhibitor and β-blocker therapy. Consecutive patients were enrolled over a 12-month period commencing in July 2010. <h3>Results</h3> In total 533 patients presented with STEMI and underwent treatment with PPCI in the study period. Of these 345 received a prasugrel loading dose and bivalirudin treatment (Group A). The remaining 188 patients received alternative therapy (Group B). Baseline demographics (Abstract 132 table 1) differ significantly between groups due to the criteria used for drug regimen selection. Procedural outcomes are summarised in Abstract 132 table 2. Procedural success was achieved in 97.6% of patients, using radial access in 79.9%. Bleeding occurred in 1.9% of all patients (Group A 1.2%). Stent thrombosis occurred in 1.1% of patients and no definite early stent thrombosis was observed in Group A. The 30-day death rate was 6% with 2.6% in Group A. <h3>Conclusions</h3> Use of bivalirudin and prasugrel in the acute treatment of STEMI demonstrates excellent efficacy and safety. The Horizons-AMI data suggested a risk of early stent thrombosis in the absence of heparin, however, our heparin-naive cohort were free of this complication. Furthermore, our combined strategy of anti-thrombotic therapy and preferred radial access maintains very low access-site complication rates. Randomised trial data confirming this strategy is awaited." @default.
• W2051578523 created "2016-06-24" @default.
• W2051578523 creator A5008059536 @default.
• W2051578523 creator A5019181024 @default.
• W2051578523 creator A5025528254 @default.
• W2051578523 creator A5033904883 @default.
• W2051578523 creator A5040953408 @default.
• W2051578523 creator A5045427810 @default.
• W2051578523 creator A5060683596 @default.
• W2051578523 date "2012-05-01" @default.
• W2051578523 modified "2023-09-23" @default.
• W2051578523 title "132 Combined prasugrel and bivalirudin treatment during primary PCI offers a safe and effective strategy in ST-elevation MI" @default.
• W2051578523 doi "https://doi.org/10.1136/heartjnl-2012-301877b.132" @default.
• W2051578523 hasPublicationYear "2012" @default.
• W2051578523 type Work @default.
• W2051578523 sameAs 2051578523 @default.
• W2051578523 citedByCount "1" @default.
• W2051578523 countsByYear W20515785232013 @default.
• W2051578523 crossrefType "journal-article" @default.
• W2051578523 hasAuthorship W2051578523A5008059536 @default.
• W2051578523 hasAuthorship W2051578523A5019181024 @default.
• W2051578523 hasAuthorship W2051578523A5025528254 @default.
• W2051578523 hasAuthorship W2051578523A5033904883 @default.
• W2051578523 hasAuthorship W2051578523A5040953408 @default.
• W2051578523 hasAuthorship W2051578523A5045427810 @default.
• W2051578523 hasAuthorship W2051578523A5060683596 @default.
• W2051578523 hasBestOaLocation W20515785231 @default.
• W2051578523 hasConcept C126322002 @default.
• W2051578523 hasConcept C164705383 @default.
• W2051578523 hasConcept C2776301958 @default.
• W2051578523 hasConcept C2776710957 @default.
• W2051578523 hasConcept C2777015399 @default.
• W2051578523 hasConcept C2777028646 @default.
• W2051578523 hasConcept C2777565915 @default.
• W2051578523 hasConcept C2777628954 @default.
• W2051578523 hasConcept C2777849778 @default.
• W2051578523 hasConcept C2777995511 @default.
• W2051578523 hasConcept C2778810321 @default.
• W2051578523 hasConcept C2779161974 @default.
• W2051578523 hasConcept C2780400711 @default.
• W2051578523 hasConcept C42219234 @default.
• W2051578523 hasConcept C45393284 @default.
• W2051578523 hasConcept C500558357 @default.
• W2051578523 hasConcept C71924100 @default.
• W2051578523 hasConceptScore W2051578523C126322002 @default.
• W2051578523 hasConceptScore W2051578523C164705383 @default.
• W2051578523 hasConceptScore W2051578523C2776301958 @default.
• W2051578523 hasConceptScore W2051578523C2776710957 @default.
• W2051578523 hasConceptScore W2051578523C2777015399 @default.
• W2051578523 hasConceptScore W2051578523C2777028646 @default.
• W2051578523 hasConceptScore W2051578523C2777565915 @default.
• W2051578523 hasConceptScore W2051578523C2777628954 @default.
• W2051578523 hasConceptScore W2051578523C2777849778 @default.
• W2051578523 hasConceptScore W2051578523C2777995511 @default.
• W2051578523 hasConceptScore W2051578523C2778810321 @default.
• W2051578523 hasConceptScore W2051578523C2779161974 @default.
• W2051578523 hasConceptScore W2051578523C2780400711 @default.
• W2051578523 hasConceptScore W2051578523C42219234 @default.
• W2051578523 hasConceptScore W2051578523C45393284 @default.
• W2051578523 hasConceptScore W2051578523C500558357 @default.
• W2051578523 hasConceptScore W2051578523C71924100 @default.
• W2051578523 hasIssue "Suppl 1" @default.
• W2051578523 hasLocation W20515785231 @default.
• W2051578523 hasOpenAccess W2051578523 @default.
• W2051578523 hasPrimaryLocation W20515785231 @default.
• W2051578523 hasRelatedWork W1983992557 @default.
• W2051578523 hasRelatedWork W2025299301 @default.
• W2051578523 hasRelatedWork W2042228130 @default.
• W2051578523 hasRelatedWork W2051578523 @default.
• W2051578523 hasRelatedWork W2127687375 @default.
• W2051578523 hasRelatedWork W2319779375 @default.
• W2051578523 hasRelatedWork W2347602860 @default.
• W2051578523 hasRelatedWork W2385764678 @default.
• W2051578523 hasRelatedWork W2531256647 @default.
• W2051578523 hasRelatedWork W4291935265 @default.
• W2051578523 hasVolume "98" @default.
• W2051578523 isParatext "false" @default.
• W2051578523 isRetracted "false" @default.
• W2051578523 magId "2051578523" @default.
• W2051578523 workType "article" @default.